Terumo Corp ADR (TRUMY)

OTC Markets
Currency in USD
16.62
-0.07(-0.42%)
Closed·
TRUMY Scorecard
Full Analysis
Has a perfect Piotroski Score of 9
TRUMY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.6016.70
52 wk Range
14.0621.22
Key Statistics
Edit
Prev. Close
16.69
Open
16.67
Day's Range
16.6-16.7
52 wk Range
14.06-21.22
Volume
91.21K
Average Volume (3m)
115.23K
1-Year Change
-5.71%
Book Value / Share
6.19
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TRUMY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 4 consecutive years

Terumo Corp ADR News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Terumo ADR Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. It operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular stent grafts, and others. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.

Compare TRUMY to Peers and Sector

Metrics to compare
TRUMY
Peers
Sector
Relationship
P/E Ratio
31.0x28.4x−0.5x
PEG Ratio
2.95−0.060.00
Price/Book
2.7x2.2x2.6x
Price / LTM Sales
3.5x2.1x3.1x
Upside (Analyst Target)
-27.9%46.1%
Fair Value Upside
Unlock24.1%6.9%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 79.01%
Dividend Yield
-
Industry Median 1.31%
Annualised payout
-
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 14, 2025
EPS / Forecast
0.0856 / 0.1331
Revenue / Forecast
1.81B / 1.71B
EPS Revisions
Last 90 days

TRUMY Income Statement

FAQ

What Is the Terumo ADR (TRUMY) Stock Price Today?

The Terumo ADR stock price today is 16.62.

What Stock Exchange Does Terumo ADR Trade On?

Terumo ADR is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Terumo ADR?

The stock symbol for Terumo ADR is "TRUMY."

What Is the Terumo ADR Market Cap?

As of today, Terumo ADR market cap is 24.62B.

What Is Terumo ADR's Earnings Per Share (TTM)?

The Terumo ADR EPS (TTM) is 79.01.

When Is the Next Terumo ADR Earnings Date?

Terumo ADR will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is TRUMY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Terumo ADR Stock Split?

Terumo ADR has split 3 times.

How Many Employees Does Terumo ADR Have?

Terumo ADR has 30591 employees.

What is the current trading status of Terumo ADR (TRUMY)?

As of 12 Jul 2025, Terumo ADR (TRUMY) is trading at a price of 16.62, with a previous close of 16.69. The stock has fluctuated within a day range of 16.60 to 16.70, while its 52-week range spans from 14.06 to 21.22.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.